Clinical Trials Directory

Trials / Completed

CompletedNCT05420610

Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution and Severe Burn Injury

Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution for Treating Adult Patients With Severe Burn Injury

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study aimed to optimize fluid resuscitation with transpulmonary thermodilution (TPTD)-guided protocol and to lower the mortality rate of the severely burned.

Conditions

Interventions

TypeNameDescription
OTHERControl group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.The control group included patients being admitted when TPTD device was unavailable; and relatively stable patients without the need for TPTD. The adequacy of fluid resuscitation in the control group was monitored by traditional monitoring parameters including vital signs and hourly urine output.
OTHERStudy group: TPTD device was implemented for monitoring.TPTD device was implemented for monitoring; the inclusion criteria included patients suffering from 2nd degree burn greater than 40% TBSA; a combined 2nd to 3rd degree burn greater than 30% TBSA; or patients with inhalation injury despite the burned surface area.

Timeline

Start date
2021-08-07
Primary completion
2021-11-30
Completion
2022-01-20
First posted
2022-06-15
Last updated
2022-06-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05420610. Inclusion in this directory is not an endorsement.